logo

For the Inventor, By the Inventor

Darmstadt, Germany

Merck Patent Gesellschaft MIT


USPTO Granted Patents = 47

% Expired Patents = 10.6

Forward Citations = 565

Loading Chart...
Loading Chart...

142 inventors (with patents filed for the assignee):

goldMedal Volker Reiffenrath (7 out of 216 patents)

silverMedal Kazuaki Tarumi (7 out of 71 patents)

bronzeMedal Matthias Bremer (5 out of 110 patents)

4.  Brigitte Schuler (5 out of 88 patents)

5.  Michael Heckmeier (5 out of 100 patents)

6.  Peer Kirsch (4 out of 120 patents)

7.  Horst Kessler (3 out of 35 patents)

8.  Sabine Schoen (3 out of 95 patents)

9.  Dagmar Klement (3 out of 14 patents)

10.  Sabine Hitzel (3 out of 10 patents)

11.  Thekla Kurz (3 out of 11 patents)

12.  Simon Lawrence Goodman (3 out of 27 patents)

13.  Eike Poetsch (3 out of 155 patents)

14.  Marcus Reuter (2 out of 35 patents)

15.  Detlef Pauluth (2 out of 103 patents)


Core Competencies:
Liquid-Crystalline Medium
Electro-Optical Display
Charge Transport Materials
Cyclic Azapeptides
Absorption-Promoting Agent
Conductive Pigment
Bicyclic Amino Acids
Pharmaceutical Composition
Optical Substrates
Grinding Aids
Cosmetic Formulation
Biological Products

47 patents:

1. 6919086 - Graminae pollen allergen mutants for specific immunotherapy, and production and use of the same (2005-07-19),
2. 6805923 - Liquid-crystalline medium (2004-10-19),
3. 6764722 - Liquid-crystalline medium (2004-07-20),
4. 6677003 - Liquid-crystalline medium (2004-01-13),
5. 6676857 - Mono-, oligo- and poly-4-fluorothiophenes and their use as charge transport materials (2004-01-13),
6. 6641871 - Liquid-crystal compound, liquid-crystal medium comprising same, and electro-optical liquid-crystal display (2003-11-04),
7. 6638581 - Liquid-crystal medium, and electro-optical display containing the medium (2003-10-28),
8. 6602562 - Electro-optical liquid-crystal display (2003-08-05),
9. 6559144 - Bicyclic amino acids (2003-05-06),
10. 6551666 - Cyclohexane derivatives and liquid-crystalline medium (2003-04-22),
11. 6534478 - Cyclic azapeptides with angiogenic effect (2003-03-18),
12. 6514524 - Orally administerable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent (2003-02-04),
13. 6509499 - Nitromethylthiobenzene derivatives as inhibitors of aldose reductase (2003-01-21),
14. 6491930 - Stable cosmetic formulation containing butylmethoxydibenzoylmethane (2002-12-10),
15. 6479302 - Method for the immunological determination of an analyte (2002-11-12),
Company Overview
Merck Patent Gesellschaft MIT, headquartered in Darmstadt, Germany, is a prominent entity in the field of biotechnology and materials science. The organization specializes in the development of innovative solutions related to Graminae pollen allergens and cyclic azapeptides, contributing to advancements in allergy treatments and pharmaceuticals. Additionally, it focuses on liquid-crystalline mediums and electro-optical displays, enhancing applications in display technologies. Its expertise extends to galenic formulations and conductive pigment mixtures, supporting diverse industrial applications.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

47 Patents

#18 in Darmstadt

#1,126 in Germany

#14,827 in the World

Darmstadt, DE
Darmstadt, Germany

Merck Patent Gesellschaft MIT

Forward Citations = 565

142 inventors:

goldMedal Volker Reiffenrath (7 out of 216 patents)

silverMedal Kazuaki Tarumi (7 out of 71 patents)

bronzeMedal Matthias Bremer (5 out of 110 patents)

4.  Brigitte Schuler (5 out of 88 patents)

5.  Michael Heckmeier (5 out of 100 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Merck Patent Gesellschaft MIT. Retrieved from https://idiyas.com/company/merck-patent-gesellschaft-mit

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…